Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells

Cell Growth and Differentiation

Volumn 9, Issue 8, 1998, Pages 629-637

  Sonneveld, Edwin ^a   Van Den Brink, Christina E ^a   Van Der Leede, Bas Jan M ^a   Schulkes, Roeland Kees A M ^a   Petkovich, Martin ^b   Van Der Burg, Bart ^a   Van Der Saag, Paul T ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; LIAROZOLE; RETINOIC ACID;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL GROWTH; COLON CARCINOMA; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME ISOLATION; ENZYME KINETICS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MICROSOME; PRIORITY JOURNAL;

BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CHROMATOGRAPHY; COLONIC NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; DNA; ENZYME INDUCTION; FEMALE; HUMANS; HYDROXYLATION; IMIDAZOLES; MICROSOMES; RECEPTORS, RETINOIC ACID; SUBSTRATE SPECIFICITY; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031870013     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. De Luca, L. M., Darwiche, N., Celli, G., Kosa, K., Jones, C., Ross, S., and Chen, L. C. Vitamin A in epithelial differentiation and skin carcinogenesis. Nutr. Rev., 52: 45-52, 1994.
2. Gudas, L. J., Sporn, M. B., and Roberts, A. B. Cellular biology and biochemistry of the retinoids. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, Ed. 2, pp. 443-520. New York: Raven Press, 1994.
3. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, Ed. 2, pp. 319-349. New York: Raven Press, 1994.
4. Napoli, J. L., Boerman, M. H. E. M., Chai, X., Zhai, Y., and Fiorella, P. D. Enzymes and binding proteins affecting retinoic acid concentrations. J. Steroid Biochem. Mol. Biol., 53: 497-502, 1995.
5. Chen, M., Achkar, C., and Gudas, L. J. Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases. Mol. Pharmacol., 46: 88-96, 1994.
6. Pijnappel, W. W. M., Hendriks, H. F. J., Folkers, G. E., van den Brink, C. E., Dekker, E. J., Edelenbosch, C., van der Saag, P. T., and Durston, A. J. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature (Lond.), 366: 340-344, 1993.
7. Wouters, W., van Dun, J., Dillen, A., Coene, M-C., Cools, W., and De Coster, R. Effects of liarozole, a new antitumor compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res., 52: 2841-2846, 1992.
8. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics, 6: 1-42, 1996.
9. Leo, M. A., Lasker, J. M., Raucy, J. L., Kim, C. L., Black, M., and Lieber, C. S. Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch. Biochem. Biophys., 269: 305-312, 1989.
10. Murray, M., Wilkinson, C. F., and Dube, C. E. Effects of dihydrosafrole on P450 and drug oxidation in hepatic microsomes from control and induced rats. Toxicol. Appl. Pharmacol., 68: 66-76, 1983.
11. Westin, S., Sonneveld, E., van der Leede, B. M., van der Saag, P. T., Gustafsson, J. A., and Mode, A. CYP2C7 expression in rat liver and hepatocytes: regulation by retinoids. Mol. Cell. Endocrinol., 129: 169-179, 1997.
12. Takatsuka, J., Takahashi, N., and De Luca, L. M. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res., 56: 675-678, 1996.
13. Van der Leede, B. M., van den Brink, C. E., Pijnappel, W. W. M., Sonneveld, E., van der Saag, P. T., and van der Burg, B. Auto-induction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells. J. Biol. Chem., 272: 17921-17928, 1997.
14. Krekels, M. D. W. G., Verhoeven, A., van Dun, J., Cools, W., Van Hove, C., Dillen, L., Coene, M-C., and Wouters, W. Induction of the oxidative catabolism of retinoic acid in MCF-7 cells. Br. J. Cancer, 75: 1098-1104, 1997.
15. White, J. A., Guo, Y-D., Baetz, K., Beckett-Jones, B., Bonasoro, J., Hsu, K. E., Dilworth, F. J., Jones, G., and Petkovich, M. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem., 271: 29922-29927, 1996.
16. Ray, W. J., Bain, G., Yao, M., and Gottlieb, D. I. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J. Biol. Chem., 272: 18702-18708, 1997.
17. White, J. A., Beckett-Jones, B., Guo, Y-D., Dilworth, F. J., Bonasoro, J., Jones, G., and Petkovich, M. cDNA cloning of human retinoic acid metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450 (CYP26). J. Biol. Chem., 272: 18538-18541, 1997.
18. Van der Burg, B., van der Leede, B. M., Kwakkenbos-Isbrücker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol-independent breast cancer cell lines coincides with diminished expression of functional retinoic acid receptors. Mol. Cell. Endocrinol., 91: 149-157, 1993.
19. Van der Leede, B. M., Opdenoordt, T., Van den Brink, C. E., Ebert, T., and Van der Saag, P. T. Implication of retinoic acid receptor β in renal cell carcinoma. Int. J. Oncol., 6: 391-400, 1995.
20. Boylan, J. F., Lufkin, T., Achkar, C. C., Taneya, R., Chambon, P., and Gudas, L. J. Targeted disruption of retinoic acid receptor α (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol., 15: 843-851, 1995.
21. Abu-Abed, S. S., Beckett, B. R., Chiba, H., Chithalen, J. V., Jones, G., Metzger, D., Chambon, P., and Petkovich, M. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor γ and retinoid X receptor α. J. Biol. Chem., 273: 2409-2415, 1998.
22. Han, I. S., and Choi, J-H. Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells. J. Clin. Endocrinol. Metab., 81: 2069-2075, 1996.
23. 3 to calcitroic acid: evidence for a pathway in kidney and bone involving 24-oxidation. Biochem. J., 262: 173-180, 1989.
24. Muindi, J., Frankel, S. R., Miller, W. H., Jakubowski, A., Scheinberg, D. A., Young, C. W., Dmitrovsky, E., and Warrell, R. P. Continuous treatment with all-trans retinoic acid results in a progressive decrease in plasma concentrations: implications for relapse and "resistance" in acute promyelocytic leukemia. Blood, 79: 299-303, 1992.
25. Takitani, K., Tamai, H., Morinobu, T., Kawamura, N., Miyake, M., Fujimoto, T., and Mino, M. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy. J. Nutr. Sci. Vitaminol., 41: 493-498, 1995.
26. Adamson, P. C., Murphy, R. F., Godwin, K. A., Ulm, E. H., and Balis, F. M. Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey. Cancer Res., 55: 482-485, 1995.
27. Van Heusden, J., Wouters, W., Ramaekers, F. C. S., Krekels, M. D. W. G., Dillen, L., Borgers, M., and Smets, G. All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro. Br. J. Cancer, 77: 26-32, 1998.
28. Van Heusden, J., Wouters, W., Ramaekers, F. C. S., Krekels, M. D. W. G., Dillen, L., Borgers, M., and Smets, G. The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells. Br. J. Cancer, 77: 1229-1235, 1998.
29. Shirley, M. A., Bennani, Y. L., Boehm, M. F., Breau, A. P., Pathirana, C., and Ulm, E. H. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Drug Metab. Dispos., 24: 293-302, 1996.
30. Takeuchi, M., Yano, T., Omoto, E., Takahashi, K., Kibata, M., Shudo, K., Ueda, R., Ohno, R., and Harada, M. Re-induction of complete remission with a new synthetic retinoid, am-80, for relapse of acute promyelocytic leukaemia previously treated with all-trans retinoic acid. Br. J. Haematol., 97: 137-140, 1997.
31. Tobita, T., Takeshita, A., Kitamura, K., Ohnishi, K., Yanagi, M., Hiraoka, A., Karasuno, T., Takeuchi, M., Miyawaki, S., Ueda, R., Naoe, T., and Ohno, R. Treatment with a new synthetic retinoid, am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood, 90: 967-973, 1997.
32. Folkers, G. E., van Heerde, E. C., and van der Saag, P. T. Activation function 1 of retinoic acid receptor β2 is an acidic activator resembling VP16. J. Biol. Chem., 270: 23552-23559, 1995.
33. Todaro, G. J., De Larco, J. E., Frijling, C., Johnson, P. A., and Sporn, M. B. Transforming growth factors (TGFs): properties and possible mechanisms of action. J. Supramol. Struct. Cell Biochem., 15: 287-301, 1981.
34. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
35. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. Basic local alignment search tool. J. Mol. Biol., 215: 403-410, 1990.
36. Murray, M., Cantrill, E., Martini, R., and Farrell, G. C. Increased expression of cytochrome P450-IIIA2 in male rat liver after dietary vitamin A supplementation. Arch. Biochem. Biophys., 286: 618-624, 1991.
37. Gaub, M. P., Lutz, Y., Ruberte, E., Petkovich, M., Brand, N., and Chambon, P. Antibodies specific to the retinoic acid human nuclear receptors α and β. Proc. Natl. Acad. Sci. USA, 86: 3089-3093, 1989.